Early switch to oral antibiotic therapy for the treatment of patients with bacterial native vertebral osteomyelitis: A quaternary center experience, systematic review, and meta-analysis

Matteo Passerini, Julian Maamari, Tarek Nayfeh, Leslie C. Hassett, Aaron J. Tande, Mohammad H Murad, Zelalem Temesgen, Elie F. Berbari

Research output: Contribution to journalReview articlepeer-review

Abstract

Recent data suggest that oral therapy can be effective for bone infections. We aim to assess the efficacy of an early switch to oral therapy (<2 weeks) compared to a non-early switch in bacterial native vertebral osteomyelitis. We conducted a cohort study at Mayo Clinic, Rochester (MN), between 2019-2021 combined with a systematic review, which queried multiple databases. Data were analyzed using a random-effects model. The cohort study included 139 patients: two received an early switch. Of 3708 citations, 13 studies were included in the final analysis. Meta-analysis demonstrated no difference in treatment failure (odds ratio=1.073, 95-0.370-3.116), but many studies presented high risk of bias. Current evidence is insufficient to conclude the proportion of patients with failure or relapse is different in the two groups. High-quality studies are warranted before early switch can be routinely recommended.

Original languageEnglish (US)
Pages (from-to)249-257
Number of pages9
JournalJournal of Bone and Joint Infection
Volume7
Issue number6
DOIs
StatePublished - Nov 23 2022

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Early switch to oral antibiotic therapy for the treatment of patients with bacterial native vertebral osteomyelitis: A quaternary center experience, systematic review, and meta-analysis'. Together they form a unique fingerprint.

Cite this